)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Evotec (EVT) investor relations material
Evotec Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary13 Aug, 2025
Executive summary
New strategy unveiled in April 2025 focuses on core technology, operational excellence, and sustainable profitable growth, with transformation efforts on track and tangible gains.
Strategic reset and organizational realignment underway, reducing complexity and increasing accountability, with completion expected by year-end.
Two core business segments now reported: Discovery & Preclinical Development (D&PD) and Just-Evotec Biologics (JEB/JEP), with JEB delivering strong growth and D&PD underperforming.
Asset-light, high-margin model pursued via planned sale of JEB Toulouse site to Sandoz, supporting monetization of technology and IP.
Strategic collaborations with BMS advanced, triggering $75m in performance-based payments and a $20m neuroscience research payment.
Financial highlights
H1 2025 group revenues reached €371.2m, a 5% decrease year-over-year, mainly due to an 11% decline in D&PD revenues; JEB revenues grew 16% to €102.2m.
Gross margin declined to 9.6% from 12.9% year-over-year, mainly due to lower D&PD performance.
Adjusted group EBITDA was negative €1.9m, with JEB contributing €7.5m and D&PD at €(9.3)m.
R&D spending reduced by 35% to €19m, aligning with new investment focus.
Net loss improved to €(75.1)m from €(115.6)m, primarily due to non-recurring reorganization costs in the prior year.
Outlook and guidance
Full-year 2025 revenue guidance: €760–800m; adjusted EBITDA: €30–50m; R&D expenditure: €40–50m.
H2 expected to mirror H1 dynamics for D&PD; JEB anticipated to see a significant step up in growth, especially in Q4.
2028 aspiration: revenue CAGR of 8–12% (2024–2028), adjusted EBITDA margin above 20%.
Foreign currency impact expected to be higher in H2 but offset by improved business mix.
Assess impact of Sandoz AG deal on JEB.
How does selective biotech funding affect Evotec?
Explain the drivers behind the gross margin decrease.
How does JEB's growth strategy improve ROI?
What's driving D&PD revenue decline?
How will the Sandoz deal impact midterm goals?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Evotec earnings date
Q3 20255 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Evotec SE is a biotechnology company specializing in drug discovery and development services. The company collaborates with pharmaceutical and biotech firms, academic institutions, and research organizations to identify and develop therapeutic candidates across various disease areas, including neurology, oncology, and metabolic disorders. The company is headquartered in Hamburg, Germany, and its shares are listed on the FSE (Frankfurt Stock Exchange).
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage